Trice Medical Scores Another $6.5 Million

Trice Medical, which has developed technology that allows doctors to diagnose orthopedic injuries in their office, has raised an additional $6.5 million in a private equity financing.

The King of Prussia, Pa., medical device company has now raised a total of $18 million through the series B financing, which was led by Safeguard Scientifics Inc. (NYSE: SFE) of Wayne, Pa.

In September, Trice received Food and Drug Administration approval for its Mi-eye product. Mi-eye is a fully disposable, single-use, visualization device.

Help employers find you! Check out all the jobs and post your resume.

Back to news